JARDIANCE
These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE (empagliflozin tablets), for oral useInitial U.S. Approval: 2014
Approved
Approval ID
f2b41c77-0abb-40ee-8578-86a748d0e19e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 3, 2023
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Empagliflozin
PRODUCT DETAILS
NDC Product Code50090-6457
Application NumberNDA204629
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateAugust 31, 2021
Generic NameEmpagliflozin
INGREDIENTS (1)
EMPAGLIFLOZINActive
Quantity: 25 mg in 1 1
Code: HDC1R2M35U
Classification: ACTIB